熱門資訊> 正文
资产负债表改善后，BioCardia重新获得纳斯达克合规性;股价上涨
2025-10-02 20:23
- BioCardia (NASDAQ:BCDA) has regained compliance with Nasdaq listing requirements.
- On October 1, 2025, Nasdaq confirmed BioCardia now meets the Equity Rule.
- Compliance follows efforts to strengthen the company’s balance sheet, including raising new capital.
- BCDA shares up 7% premarket on Thursday.
- Source: Press release
More on BioCardia
- BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript
- BioCardia announces pricing of up to $12M public offering
- BioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025
- Seeking Alpha’s Quant Rating on BioCardia
- Historical earnings data for BioCardia
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
